Literature DB >> 4656604

The effect of sodium -hydroxybutyrate on the metabolism of dopamine in the brain.

D A Hutchins, K S Rayevsky, D F Sharman.   

Abstract

1. Sodium gamma hydroxybutyrate (GHB-Na), when given to rats and mice, caused a sleep-like state and a fall in body temperature of about 10 degrees C.2. GHB-Na produced a dose-dependent increase in the concentration of dopamine (DA) in the brains of mice kept at an environmental temperature of 18-20 degrees C or 30-32 degrees C.3. The concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC) and 4-hydroxy-3-methoxyphenylacetic acid (HVA), the metabolites of DA, were increased in the striatal tissues of rats and mice, after the administration of GHB-Na. However there was a delay of 60 min before the concentration of HVA increased whereas there appeared to be little delay before the concentration of DOPAC increased.4. When GHB-Na was administered to reserpine-treated animals, no increase occurred in the concentration of dopamine in the brains of mice or rats, or of DOPAC in the rat brain.5. Reserpine did not prevent the induction of the sleep-like state by GHB-Na.6. The results presented suggest that the effect of GHB-Na in increasing the concentration of DA requires unimpaired storage mechanisms for the amine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4656604      PMCID: PMC1666526          DOI: 10.1111/j.1476-5381.1972.tb08138.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate.

Authors:  P F Spano; A Tagliamonte; P Tagliamonte; G L Gessa
Journal:  J Neurochem       Date:  1971-10       Impact factor: 5.372

2.  On the mode of action of reserpine on dopamine metabolism in the rat striatum.

Authors:  H C Guldberg; O J Broch
Journal:  Eur J Pharmacol       Date:  1971-01       Impact factor: 4.432

3.  Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid.

Authors:  R H Roth
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

4.  Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action.

Authors:  G L Gessa; F Crabai; L Yargiu; P F Spano
Journal:  J Neurochem       Date:  1968-05       Impact factor: 5.372

5.  Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate.

Authors:  R H Roth; N J Giarman
Journal:  Biochem Pharmacol       Date:  1968-05       Impact factor: 5.858

6.  Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

Authors:  R H Roth; Y Suhr
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

7.  Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain.

Authors:  R H Roth
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

8.  Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1966-11

9.  The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse.

Authors:  G F Murphy; D Robinson; D F Sharman
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

10.  3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine?

Authors:  S Roffler-Tarlov; D F Sharman; P Tegerdine
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

View more
  10 in total

1.  Proceedings: The effects of depleting brain amines on the behavioural actions of gamma-hydroxybutyric acid.

Authors:  D A Benton; J T Rick; P V Taberner
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

2.  Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.

Authors:  N E Andén; T Magnusson; G Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow.

Authors:  G Stock; T Magnusson; N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  The effect of low doses of d-amphetamine on drug-induced hyperactivity in the mouse.

Authors:  J S Hussey; N D Vincent; J A Davies
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Suppression of ethanol-induced locomotor stimulation by GABA-like drugs.

Authors:  J Cott; A Carlsson; J Engel; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

6.  Gammahydroxybutyrate (GHB) receptor ligand effects on evoked synaptic field potentials in CA1 of the rat hippocampal slice.

Authors:  M A King; J S Thinschmidt; D W Walker
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid.

Authors:  K Menon; D Bieger; O Hornykiewicz
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

8.  The effect of gamma-hydroxybutyrate on mouse striatal tyramine, dopamine and homovanillic acid.

Authors:  A V Juorio
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

9.  Effect of diazepam on dopamine and homovanillic acid levels in the corpus striatum of rats pretreated with γ-hydroxybutyric acid.

Authors:  M Massotti
Journal:  Neurochem Res       Date:  1977-12       Impact factor: 3.996

Review 10.  When "Chems" Meet Sex: A Rising Phenomenon Called "ChemSex".

Authors:  Raffaele Giorgetti; Adriano Tagliabracci; Fabrizio Schifano; Simona Zaami; Enrico Marinelli; Francesco Paolo Busardò
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.